Amicus Therapeutics (NASDAQ:FOLD) Upgraded by StockNews.com to Buy

[VUBot]

StockNews.com raised Amicus Therapeutics from a "hold" rating to a "buy" rating in a research report on Wednesday.

Continue reading...